• Friday, 05 December 2025
Dr. Risteski for MIA: Ivermectin could be a powerful ally, but lacks funding interest due to low profit potential

Dr. Risteski for MIA: Ivermectin could be a powerful ally, but lacks funding interest due to low profit potential

Skopje, 16 July 2025 There are different approaches to cancer therapy, depending on the tumo...

Image